VALZIFLOCEPT
UNII EA2075XV4Y

Substance Identification & Data

This profile provides standardized clinical and technical data for Valziflocept, uniquely identified by the FDA Unique Ingredient Identifier (UNII) EA2075XV4Y.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1804910-11-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
EA2075XV4Y
CAS Registry Number
1804910-11-9
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
VALZIFLOCEPT
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
10457
Sequential identifier assigned via the WHO International Nonproprietary Name program.
USAN ID
EF-112
Identifier assigned by the United States Adopted Names Council.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Valziflocept. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

VALZIFLOCEPT

Common Names & Synonyms

FC.GAMMA.RIIB RECEPTOR (HUMAN SOLUBLE EXTRACELLULAR FRAGMENT)
HUMAN IMMUNOGLOBULIN GAMMA FC REGION RECEPTOR II-B (FC.GAMMA.RII-B), EXTRACELLULAR N-TERMINAL FRAGMENT, PRODUCED IN ESCHERICHIA COLI
RECOMBINANT HUMAN SOLUBLE FC-GAMMA RECEPTOR IIB
RECOMBINANT, SOLUBLE, NON-GLYCOSYLATED VERSION OF FC GAMMA RECEPTOR IIB
VALZIFLOCEPT [INN]
VALZIFLOCEPT [USAN]
VALZIFLOCEPT [WHO-DD]

Technical Codes

SHP652
SHP-652
SM101
SM-101